Will Flatiron Benchtop Dilution Refrigerator Shift FormFactor's (FORM) Quantum Tooling Narrative?

• In March 2026, FormFactor, Inc. launched the Flatiron Dilution Refrigerator, a compact horizontal benchtop system that delivers ~30 mK performance, faster sample access, and integrated optical windows to streamline sub-kelvin optical and electrical measurements for quantum device research and industrial development.
• By shrinking millikelvin experimentation into an ergonomic, lab-ready platform that supports frequent thermal cycling, Flatiron aims to ease a key testing bottleneck for quantum hardware teams and could strengthen FormFactor’s role in quantum technology tooling.
• We’ll now examine how this benchtop millikelvin platform, designed to speed quantum hardware validation, may influence FormFactor’s existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

FormFactor Investment Narrative Recap

To own FormFactor, you need to believe its test and measurement tools can stay central as chips get more complex and quantum research scales. The Flatiron Dilution Refrigerator fits that story by extending FormFactor’s reach into quantum device validation, but it does not obviously change near term earnings drivers or the main risk around sustaining healthier gross margins under product mix and cost pressures.

Among recent announcements, the 2026 first quarter guidance, calling for revenue of about US$225 million plus or minus US$5 million, is most relevant when thinking about Flatiron. Any traction from this benchtop millikelvin platform would flow through that same income statement and could, over time, interact with the existing catalysts around AI driven test demand and capacity investments, but it sits alongside rather than replacing them.

Yet behind the appeal of quantum tools, investors should still be aware that concentrated DRAM and HBM exposure could...

Read the full narrative on FormFactor (it's free!)

FormFactor's narrative projects $984.3 million revenue and $97.0 million earnings by 2028. This requires 8.8% yearly revenue growth and about a $53.1 million earnings increase from $43.9 million today.

Uncover how FormFactor's forecasts yield a $84.11 fair value, a 8% downside to its current price.

Exploring Other Perspectives

Before Flatiron, the most bearish analysts were assuming revenue of about US$925.3 million and earnings of US$91.3 million by 2028, which contrasts sharply with the more optimistic catalyst around advanced packaging and quantum testing, and shows how much more cautious some views are likely to remain even if this new product eventually shifts expectations.

Explore 6 other fair value estimates on FormFactor - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your FormFactor research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free FormFactor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FormFactor's overall financial health at a glance.

Interested In Other Possibilities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com